For anyone who was unable to join our September 23rd webinar, Building a Cannabis Business in New York: An Operator’s Perspective, we’ve got you covered! Below, please find the full presentation for your viewing pleasure. You can download the transcript HERE. Stay up to date on cannabis in New York via the Canna Law Blog.
Last week, AB-45 completed its run through the California legislature and was presented to Governor Gavin Newsom for his signature, which is probably imminent. Once he signs it, the law takes effect and will pave the way for legal CBD consumables, while banning (at least temporarily) any kind of hemp-derived inhalable product. If you want
By and large, cannabis businesses are small businesses. We’ve represented hundreds of these businesses over the years, in many states. Within these businesses one finds many kinds of people. They include legacy operators transitioning from traditional markets, to well-heeled investors coming from industries like banking and private equity. And everyone in between. Of course, performance
Recently, we covered Sacha Baron Cohen and his company’s copyright infringement lawsuit against Massachusetts dispensary Solar Therapeutics, its President and Director, Edward Dow III, filed a motion to dismiss this week for failure to demonstrate Mr. Dow is personally liable for Solar’s conduct. As we mentioned in the last post, personal liability is not something
Register HERE! As New York entrepreneurs gear up to apply for state licenses to produce and sell regulated cannabis products, there are many unknowns surrounding how the business environment will develop. Michael Dundas founded and led one of the largest regulated cannabis businesses in Massachusetts from the inception of its medical program in 2012 until
I’ve preached before on the blog about how often our firm gets pulled into M&A deals where the parties have screwed up reporting the transaction to cannabis regulators on both the state and local levels. In California, in particular, changes of ownership have been a painful affair where the Bureau of Cannabis Control (“BCC”) routinely
It’s been a while since I provided an update on the state of California psychedelics law, but there have been a few important updates in the last few weeks, so it’s now that time. Before jumping in, I’ll remind readers that currently, all psychedelics are illegal under federal law unless a person has received an
Many ketamine clinics enter into management agreements with management services organizations (“MSO”). The MSO provides a litany of services to the professional entities (“PE”) that are owned by healthcare providers, including billing and collections, financial and accounting services, providing space to the clinic through a lease, strategic planning, marketing, and many other types of management
On Tuesday, the Food and Drug Administration (the “FDA”) released its first statement via a consumer update regarding Delta-8 tetrahydrocannabinol (“Delta-8 THC”). The agency decided to provide consumers with key information surrounding the popular cannabinoid following a sharp increase in adverse event reports involving the substance and unauthorized marketing practices directed at minors. If you
We don’t write about criminal cases often, but a recent decision from the Minnesota Court of Appeals caught my eye because of its potential impact on the people of Minnesota and businesses engaged in processing, manufacturing, possession, or selling of Hemp/CBD in Minnesota. This ruling affects manufacturers, processors, sellers, distributors, and consumers of any liquid
